Effect of the Urinary Tryptin Inhibitor Ulinastatin on Cardiopulmonary Bypass-Related Inflammatory Response and Clinical Outcomes: A Meta-Analysis of Randomized Controlled Trials

Clinical Therapeutics

Volumn 37, Issue 3, 2015, Pages 643-653

  He, Siyi ^a,b   Lin, Kailong ^a   Ma, Ruiyan ^a   Xu, Rufu ^a   Xiao, Yingbin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

cardioprotection; cardiopulmonary bypass; inflammatory response; ulinastatin

Indexed keywords

CYTOKINE; GLYCOPROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; INTERLEUKIN 8; TNF PROTEIN, HUMAN; TRYPSIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ADVERSE EFFECTS; BLOOD; CARDIOPULMONARY BYPASS; HUMAN; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARDIOPULMONARY BYPASS; CYTOKINES; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRYPSIN INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939955884     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.12.015     Document Type: Article

References (32)

1. O.J. Warren, A.J. Smith, and C. Alexiou The inflammatory response to cardiopulmonary bypass: part 1 - mechanisms of pathogenesis J Cardiothorac Vasc Anesth 23 2009 223 231
2. D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur J Cardiothorac Surg 21 2002 232 244
3. M.C. Kapoor, and T.R. Ramachandran Inflammatory response to cardiac surgery and strategies to overcome it Ann Card Anaesth 7 2004 113 128
4. R. Ben-Abraham, A.A. Weinbroum, and B. Dekel Chemokines and the inflammatory response following cardiopulmonary bypass - a new target for therapeutic intervention? A review Paediatr Anaesth 13 2003 655 661
5. G. Asimakopoulos, P.L. Smith, and C.P. Ratnatunga Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass Ann Thorac Surg 68 1999 1107 1115
6. P.K. Shah Targeting the proteolytic arsenal of neutrophils. A promising approach for postpump syndrome and ARDS Circulation 100 1999 333 334
7. P.R. Hansen Role of neutrophils in myocardial ischemia and reperfusion Circulation 91 1995 1872 1885
8. M. Ogawa, S. Nishibe, and T. Mori Effect of human urinary trypsin inhibitor on granulocyte elastase activity Res Commun Chem Pathol Pharmacol 55 1987 271 274
9. O.A. Binns, N.F. DeLima, and S.A. Buchanan Neutrophil endopeptidase inhibitor improves pulmonary function during reperfusion after eighteen-hour preservation J Thorac Cardiovasc Surg 112 1996 607 613
10. M. Fujii, Y. Miyagi, and R. Bessho Effect of a neutrophil elastase inhibitor on acute lung injury after cardiopulmonary bypass Interact Cardiovasc Thorac Surg 10 2010 859 862
11. N. Kanayama, A. Halim, and K. Maehara Kunitz-type trypsin inhibitor prevents LPS-induced increase of cytosolic free Ca2+ in human neutrophils and HUVEC cells Biochem Biophys Res Commun 207 1995 324 330
12. Z.L. Cao, Y. Okazaki, and K. Naito Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart Ann Thorac Surg 69 2000 1121 1126
13. I.W. Shin, J.S. Jang, and S.M. Lee Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model Korean J Anesthesiol 61 2011 499 505
14. H.B. Bae, C.W. Jeong, and M. Li Effects of urinary trypsin inhibitor on lipopolysaccharide-induced acute lung injury in rabbits Inflammation 35 2012 176 182
15. Y.Z. Cao, Y.Y. Tu, and X. Chen Protective effect of ulinastatin against murine models of sepsis: inhibition of TNF-alpha and IL-6 and augmentation of IL-10 and IL-13 Exp Toxicol Pathol 64 2012 543 547
16. X. Wang, Q. Xue, and F. Yan Ulinastatin as a neuroprotective and anti-inflammatory agent in infant piglets model undergoing surgery on hypothermic low-flow cardiopulmonary bypass Paediatr Anaesth 23 2013 209 216
17. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 2010 336 341
18. H.D. Clark, G.A. Wells, and C. Huet Assessing the quality of randomized trials: reliability of the Jadad scale Controlled clinical trials 20 1999 448 452
19. Q. Zhou, G. Wang, and C. Gao [Effect of ulinastatin on perioperative inflammatory response to coronary artery bypass grafting with cardiopulmonary bypass] Zhong Nan Da Xue Xue Bao Yi Xue Ban 35 2010 107 110
20. Y.F. Jiang, W.W. Wang, and W.L. Ye [Effects of alprostadil and ulinastatin on inflammatory response and lung injury after cardiopulmonary bypass in pediatric patients with congenital heart diseases] Zhonghua Yi Xue Za Zhi 88 2008 2893 2897
21. X.Y. Yu, and L.L. Fa. [Effects of different doses of ulinastatin on inflammatory response and pulmonary function after cardiopulmonary bypass] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21 2009 664 667
22. A. Hiyama, J. Takeda, and Y. Kotake A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass J Cardiothorac Vasc Anesth 11 1997 580 584
23. T. Sugita, S. Watarida, and K. Katsuyama Effect of a human urinary protease inhibitor (ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass J Cardiovasc Surg (Torino) 43 2002 437 440
24. K. Nakanishi, S. Takeda, and A. Sakamoto Effects of ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction Crit Care Med 34 2006 1351 1357
25. J. Bingyang, L. Jinping, and L. Mingzheng Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response J Cardiovasc Surg (Torino) 48 2007 497 503
26. X. Zhang, Y. Wang, and H. Zhou Effect of ulinastatin on expression of S100beta protein and TNF-alpha in patients undergoing open-heart surgery with cardiopulmonary bypass Chinese J Emerg Med 16 2007 50 53
27. S.Y. Oh, J.C. Kim, and Y.S. Choi Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass Korean J Anesthesiol 62 2012 148 153
28. T. Kawamura, K. Inada, and N. Akasaka Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery Can J Anaesth 43 1996 456 460
29. B. Jungwirth, B. Eckel, and M. Blobner The impact of cardiopulmonary bypass on systemic interleukin-6 release, cerebral nuclear factor-kappa B expression, and neurocognitive outcome in rats Anesth Analg 110 2010 312 320
30. P. Mayer, K. Geissler, and P. Valent Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates Exp Hematol 19 1991 688 696
31. L. Skov, F.J. Beurskens, and C.O. Zachariae IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis J Immunol 181 2008 669 679
32. R.A. Lindemann. The regulatory effects of monocytes on human natural killer cells activated by lipopolysaccharides J Periodontal Res 26 1991 486 490